Good Morining listeners! To get new information on hair loss and advanced hair restoration treatments and procedures, listen to the stream live on www.wbzt.com or 1230AM in Palm Beach FL this morning (9/26/09) from 9am-10am ET. Radio host, Dr. Vinne Dolce, will have board-certified hair restoration surgeon, Dr. Alan Bauman, as a guest to discuss the revolutionary NeoGraft device and minimally-invasive hair transplant surgery. Other topics will include eyelash transplant procedures, the FDA-approved eyelash growth medication, Latisse, and the latest breakthrough in non-surgical body-slimming: The Zerona Laser.
This Friday, September 25, 2009, both the Zerona body-slimming laser and the minimally-invasive NeoGraft hair transplant device is due to be featured on Rachael Ray. Zerona is a non-invasive body-slimming procedure which has been scientifically-researched and proven in clinical trials to reduce body-circumference without the pain, recovery, risk or downtime of liposuction surgery. NeoGraft is a new breakthrough device for minimally-invasive hair transplant procedures (called Follicular Unit Extraction or FUE) which allows individual hair follicles to be harvested from the back of the scalp with no scalpel, no stitches and no linear scar. Healing and recovery is faster and more comfortable than traditional techniques and very short haircuts are possible post-op because there is no tell-tale linear scar.
Learn more about the Zerona laser or NeoGraft Hair Transplant Procedures at www.baumanmedical.com
Dr. Bauman has performed FUE procedures since 2002 and was one of the first physicans in the world to provide Zerona laser treatments to his patients. Dr. Bauman is located in Boca Raton, Florida.
NOTE: Due to the risk of a birth defect in a developing male fetus, Propecia/finasteride or Avodart/dutasteride should not be taken by women who are pregnant or may become pregnant.
This is the simlar kind of research that was performed on Propecia/finasteride prior to its FDA-approval, which has also been reported to be safe for use in the male while the female partner is pregnant. Similar recommendations and warnings have been made regarding broken/crushed tablets of Propecia/finasteride.
For other questions about the use of Avodart/Dutasteride or Propecia/Finasteride during pregnancy, email firstname.lastname@example.org
By direct email correspondence this week with Dr. Bauman, an official Allergan representative confirms the rumor that Dr. Scott Whitcup (Allergan's Executive VP of R&D) mentioned during a recent Q2 earnings conference call that they (Allergan) are in the "very early stages of exploring different formulations of bimatoprost to stimulate hair growth on the scalp." The representative described that Allergan's "near-term focus in this area will be on idenfying the appropriate formulation, initiating preclinical studies required for the FDA and working toward a sNDA submission."
Allergan's eyelash growth drug, Latisse (bimatoprost 0.03% solution), received FDA-approval for the treatment of eyelash hypotrichosis in December of 2008.